[
  {
    "companyName": "Silgan Dispensing Systems",
    "marcsCmsId": "734538",
    "postedDate": "2026-10-13",
    "letterIssueDate": "2026-10-05",
    "issuingOffice": "Center for Drug Evaluation and Research (CDER)",
    "hasPostedResponse": false,
    "hasPostedCloseout": false,
    "letterUrl": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/silgan-dispensing-systems-734538-10052026",
    "observedAt": "2026-10-18T13:05:13.258Z"
  },
  {
    "companyName": "RDM Express Inc.",
    "marcsCmsId": "729223",
    "postedDate": "2026-10-13",
    "letterIssueDate": "2026-09-11",
    "issuingOffice": "Human Foods Program",
    "hasPostedResponse": false,
    "hasPostedCloseout": false,
    "letterUrl": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/rdm-express-inc-729223-09112026",
    "observedAt": "2026-10-18T13:05:13.258Z"
  },
  {
    "companyName": "Ocean Pride Seafood, Inc.",
    "marcsCmsId": "730154",
    "postedDate": "2026-10-13",
    "letterIssueDate": "2026-09-11",
    "issuingOffice": "Human Foods Program",
    "hasPostedResponse": false,
    "hasPostedCloseout": false,
    "letterUrl": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ocean-pride-seafood-inc-730154-09112026",
    "observedAt": "2026-10-18T13:05:13.258Z"
  },
  {
    "companyName": "John & Nicole Santos Dairy",
    "marcsCmsId": "735859",
    "postedDate": "2026-10-13",
    "letterIssueDate": "2026-10-02",
    "issuingOffice": "Center for Veterinary Medicine",
    "hasPostedResponse": false,
    "hasPostedCloseout": false,
    "letterUrl": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/john-nicole-santos-dairy-735859-10022026",
    "observedAt": "2026-10-18T13:05:13.258Z"
  },
  {
    "companyName": "Lovelace Biomedical Research Institute",
    "marcsCmsId": "725136",
    "postedDate": "2026-10-13",
    "letterIssueDate": "2026-10-06",
    "issuingOffice": "Center for Drug Evaluation and Research (CDER)",
    "hasPostedResponse": false,
    "hasPostedCloseout": false,
    "letterUrl": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/lovelace-biomedical-research-institute-725136-10062026",
    "observedAt": "2026-10-18T13:05:13.258Z"
  }
]